Private genetic testing for breast cancer risk

A new partnership between BreastHealth UK (BHUK) and Lab21 Ltd aims to offer women predictive genetic testing for breast cancer risk. BHUK, which offers personalised, private breast screening services, has launched a Breast Health Risk Assessment Service.

The range of tests used for diagnoses by Lab21 include the deCODE BreastCancer assay and the Myriad assays. ‘The deCODE BreastCancer test, which has been validated in more than 100,000 women, will be offered as part of an overall breast cancer risk assessment that takes into account family history and lifestyle factors using the Tyrer-Cuzick model,’ the firms report. ‘Results will be provided in consultation with an experienced breast surgeon to interpret them and recommend potential follow-up breast screening as required.’
‘The Myriad BRCA1 and BRCA2 genetic tests are suitable for women with a strong family history of breast cancer and specialist counselling is provided to support women that require this test. The Myriad BRCA tests are based on extensive clinical research and are currently the only tests available which address predisposition to familial (inherited) breast cancer.’
BHUK is expanding its number of UK clinics via the Spire Healthcare hospital network.

01.05.2009

News • Lung cancer CT notification

Breast cancer: Keep CALM – and coordinate your screenings

Many women over 50 schedule mammograms for breast cancer but miss out on CT lung cancer screenings they're also eligible for. Targeted outreach coul help change this, a new study shows.

Article • Management of escalating imaging workload

Breast cancer screening: growing with the challenge

Rising attendance in mammography screening programmes attest to the fact that women understand the importance of early breast cancer detection. However, the resulting workload increase is a growing…

News • Lifetime risk thresholds for mastectomy

Breast cancer: When should clinicians offer surgical options?

When should preventive mastectomy be offered for women at higher risk of breast cancer? A new evaluation model defines thresholds at which risk reducing surgery should be recommended.